On February 27, Jinshi Data reported that the net profit of Kexing Pharmaceuticals in 2024 was 31.5315 million yuan, compared to a net loss of 190 million yuan in the same period last year, turning losses into profits.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Cansino Biologics: The net profit in 2024 was 31.5315 million yuan, turning losses into profits year-on-year.
On February 27, Jinshi Data reported that the net profit of Kexing Pharmaceuticals in 2024 was 31.5315 million yuan, compared to a net loss of 190 million yuan in the same period last year, turning losses into profits.